BioSpace News Archive

Ventyx Biosciences, Inc. announced the appointment of William Sandborn, MD, as President and Chief Medical Officer.

Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced it will host a live webcast on Monday, May 16, 2022, at 8:30 a.m. ET to report its first quarter 2022 financial results and provide a business update.

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the launch of an initiative to provide Human Acellular Vessels (HAVs) to multiple hospitals in Ukraine for the treatment of wounded civilians and soldiers with vascular injury, with the first shipment of HAVs departing the U.S. today.

Aadi Bioscience, Inc. announced partnerships with prominent next generation sequencing providers and leaders in genomic testing and profiling, including Foundation Medicine, Tempus and others.

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its first quarter ended March 31, 2022.

Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology.

Comera Life Sciences, Inc. today announced it has entered into a research collaboration with a top 10 global pharmaceutical company and developer of medicines across oncology, hematology and immunology and other therapeutic areas.

Ventus Therapeutics, Inc. announced today that it has been awarded a Lupus Research Program Idea Award from the U.S. Department of Defense (DoD).

Element Biosciences Inc. today announced the appointment of Kelly Choi, MD, as Senior Vice President, Marketing and Product Management.

Cognito Therapeutics today announced it has joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measures Development Project to support the advancement of its late-stage disease-modifying therapeutics pipeline for neurodegenerative diseases.